2-[(2R)-Piperazin-2-yl]acetonitrile dihydrochloride, 97%, 250mg

(2S)-1-BOC-2-METHYL-2-(METHYLAMINOMETHYL)PYRROLIDINE, 95.0%, 1g

TERT-BUTYL 2-(4-OXOCYCLOHEXYL) ETHYLCARBAMATE, 95.0%, 1g

2-Nitro-4-methoxybenzoic acid, 95.0%, 10g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.35 µm, 1 Piece(s)

(2-(HYDROXYMETHYL)PYRIDIN-4-YL)BORONIC ACID, 95.0%, 250mg

5-BROMO-2-TRIFLUOROMETHYLPYRIDINE-4-BORONIC ACID, 95.0%, 1g

1-(1-Methyl-1H-indazol-7-yl)ethanone, 95.0%, 100mg

4-Chloro-2-(trifluoromethyl)phenol, 95.0%, 10g

tert-Butyl (9-aminononyl)carbamate, 97.0%, 1g

3-(2-chlorophenyl)-4-phenyl-1,2,4-triazoline-5-thione, 98%, 98.0%, 2g

4-Amino-3-(3-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, 95%, 1g

N-(4-Methyl-pyridin-2-yl)-acetamide, 97.0%, 100mg